Trial · NCT02881008
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Patients With HBsAg Response at 12 Week of Therapy | Arm A | 0 | Participants | ||
| Proportion of Patients With HBsAg Response at 12 Week of Therapy | Arm B | 0 | Participants | ||
| Proportion of Patients With HBsAg Response at 12 Week of Therapy | Arm C | 1 | Participants | ||
| Proportion of Patients With HBsAg Response at 12 Week of Therapy | Arm D | 0 | Participants | ||
| Proportion of Patients With HBsAg Response at 12 Week of Therapy | Arm E | 0 | Participants | ||
| Proportion of Patients With HBsAg Response at 12 Week of Therapy | Arm F | 0 | Participants | ||
| Proportion of Patients With HBsAg Response at 24 Week of Therapy | Arm D | 0 | Participants | ||
| Proportion of Patients With HBsAg Response at 24 Week of Therapy | Arm F | 0 | Participants | ||
| Proportion of Patients With HBV DNA Response at Week 12 of Therapy | Arm A | 2 | Participants | ||
| Proportion of Patients With HBV DNA Response at Week 12 of Therapy | Arm B | 0 | Participants | ||
| Proportion of Patients With HBV DNA Response at Week 12 of Therapy | Arm C | 2 | Participants | ||
| Proportion of Patients With HBV DNA Response at Week 12 of Therapy | Arm D | 8 | Participants | ||
| Proportion of Patients With HBV DNA Response at Week 12 of Therapy | Arm E | 1 | Participants | ||
| Proportion of Patients With HBV DNA Response at Week 12 of Therapy | Arm F | 6 | Participants | ||
| Proportion of Patients With Biochemical Response at 12 Weeks of Therapy | Arm A | 3 | Participants | ||
| Proportion of Patients With Biochemical Response at 12 Weeks of Therapy | Arm B | 4 | Participants | ||
| Proportion of Patients With Biochemical Response at 12 Weeks of Therapy | Arm C | 4 | Participants | ||
| Proportion of Patients With Biochemical Response at 12 Weeks of Therapy | Arm D | 4 | Participants | ||
| Proportion of Patients With Biochemical Response at 12 Weeks of Therapy | Arm E | 2 | Participants | ||
| Proportion of Patients With Biochemical Response at 12 Weeks of Therapy | Arm F | 4 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02881008/results